Outpace Bio
Seattle, WA
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
outpacebio.comCompany Details
Founded
- 2020
Employees
- Between 50 - 100 employees
Raised
- $55,000,000
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
- Marc Lajoie
Founders
- Scott BoykenMarc Lajoie
Company Collections
These are collections Outpace Bio is a part of. Click on the collection name to view similar companies.